Filter Results

Clear All Filters

Contributor

Displaying 7 results for

GO
Search Filters: Florida cancel Indiana cancel Policy cancel Population Health and Prevention cancel

ASTHO Policy Watch 2022: Mental Health

Blog,
Ohio,

Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—this post focuses on mental and behavioral health, as well as supporting the public health workforce.

More States Consider Restricting Sale of Flavored Tobacco Products

Blog,

A pressing public health issue before the COVID-19 pandemic hit, the need for public health interventions to reduce tobacco use is heightened with a strong association between tobacco use, in all forms, with severe COVID-19 outcomes. ...

States Increasing Supports for Early Childhood Programs

Blog,
Utah,

Looking to the future, states are improving access to care, providing subsidies for tuition costs, expanding hours of licensed facilities, increasing access, and meeting the needs of both parents and children.

Proposed Vaccination Laws to Watch in the New Year

Blog,
STIs,
HIV,
PFAS,

Vaccines are one of the greatest public health achievements of the last century, as well as some of the most powerful and cost-effective tools to prevent disease, disparities, disability, and death among children and adults. The COVID-19 ...

Legislative Action Bridging Public Health and Clinical Healthcare

Blog,
Iowa,

Three ways policymakers are addressing access to care are through telehealth, safety net and emergency services, and adjusted reimbursement rates to Medicaid-enrolled providers.

2023 Legislative Session Update: Part One

Blog,
STIs,
HIV,
PFAS,
Guam,
Utah,

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Guam,
Utah,
Blog,

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...